The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 87 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Antifungal Agents  [Clear All Filters]
2016
Pana, Z. Dorothea, Seidel D., Skiada A., Groll A. H., Petrikkos G., Cornely O. A., et al. (2016).  Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.. BMC Infect Dis. 16(1), 667.
Roilides, E., & Antachopoulos C. (2016).  Isavuconazole: an azole active against mucormycosis.. Lancet Infect Dis. 16(7), 761-762.
2015
Samalidou, M., Bougiouklis D., Vyzantiadis T-A., Meletiadis J., Monokrousos N., Siotou E., et al. (2015).  In vitro and in vivo study on the effect of antifungal agents on hematopoietic cells in mice.. Exp Biol Med (Maywood). 240(12), 1728-34.
Katragkou, A., McCarthy M., Alexander E. L., Antachopoulos C., Meletiadis J., Jabra-Rizk M. Ann, et al. (2015).  In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.. J Antimicrob Chemother. 70(2), 470-8.
Tragiannidis, A., Tsoulas C., & Groll A. H. (2015).  Invasive candidiasis and candidaemia in neonates and children: update on current guidelines.. Mycoses. 58(1), 10-21.
Lestner, J. M., Versporten A., Doerholt K., Warris A., Roilides E., Sharland M., et al. (2015).  Systemic antifungal prescribing in neonates and children: outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) Study.. Antimicrob Agents Chemother. 59(2), 782-9.
Pana, Z-D., Kougia V., & Roilides E. (2015).  Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update.. Expert Opin Pharmacother. 16(5), 693-710.
2014
Gamaletsou, M. N., Rammaert B., Bueno M. A., Moriyama B., Sipsas N. V., Kontoyiannis D. P., et al. (2014).  Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome.. J Infect. 68(5), 478-93.
Simitsopoulou, M., Kyrpitzi D., Velegraki A., Walsh T. J., & Roilides E. (2014).  Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.. Antimicrob Agents Chemother. 58(8), 4953-6.
Cornely, O. A., Arikan-Akdagli S., Dannaoui E., Groll A. H., Lagrou K., Chakrabarti A., et al. (2014).  ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.. Clin Microbiol Infect. 20 Suppl 3, 5-26.
Chowdhary, A., Meis J. F., Guarro J., de Hoog G. S., Kathuria S., Arendrup M. C., et al. (2014).  ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi.. Clin Microbiol Infect. 20 Suppl 3, 47-75.
Tortorano, A. M., Richardson M., Roilides E., van Diepeningen A., Caira M., Muñoz P., et al. (2014).  ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.. Clin Microbiol Infect. 20 Suppl 3, 27-46.
Katragkou, A., Pana Z-D., Perlin D. S., Kontoyiannis D. P., Walsh T. J., & Roilides E. (2014).  Exserohilum infections: review of 48 cases before the 2012 United States outbreak.. Med Mycol. 52(4), 376-86.
Groll, A. H., Castagnola E., Cesaro S., Dalle J-H., Engelhard D., Hope W., et al. (2014).  Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation.. Lancet Oncol. 15(8), e327-40.
Katragkou, A., McCarthy M., Meletiadis J., Petraitis V., Moradi P. W., Strauss G. E., et al. (2014).  In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds.. Antimicrob Agents Chemother. 58(11), 6934-7.
Manzoni, P., Wu C., Tweddle L., & Roilides E. (2014).  Micafungin in premature and non-premature infants: a systematic review of 9 clinical trials.. Pediatr Infect Dis J. 33(11), e291-8.
Roilides, E., Antachopoulos C., & Simitsopoulou M. (2014).  Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs.. Mycoses. 57 Suppl 3, 40-7.
Katragkou, A., Walsh T. J., & Roilides E. (2014).  Why is mucormycosis more difficult to cure than more common mycoses?. Clin Microbiol Infect. 20 Suppl 6, 74-81.
2013
Vogiatzi, L., Ilia S., Sideri G., Vagelakoudi E., Vassilopoulou M., Sdougka M., et al. (2013).  Invasive candidiasis in pediatric intensive care in Greece: a nationwide study.. Intensive Care Med. 39(12), 2188-95.
Tragiannidis, A., Tsoulas C., Kerl K., & Groll A. H. (2013).  Invasive candidiasis: update on current pharmacotherapy options and future perspectives.. Expert Opin Pharmacother. 14(11), 1515-28.
Dotis, J., Pana Z. Dorothea, & Roilides E. (2013).  Non-Aspergillus fungal infections in chronic granulomatous disease.. Mycoses. 56(4), 449-62.
Bassetti, M., Marchetti M., Chakrabarti A., Colizza S., Garnacho-Montero J., Kett D. H., et al. (2013).  A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts.. Intensive Care Med. 39(12), 2092-106.
Kontoyiannis, D. P., Perlin D. S., Roilides E., & Walsh T. J. (2013).  What can we learn and what do we need to know amidst the iatrogenic outbreak of Exserohilum rostratum meningitis?. Clin Infect Dis. 57(6), 853-9.
2012
Gamaletsou, M. N., Kontoyiannis D. P., Sipsas N. V., Moriyama B., Alexander E., Roilides E., et al. (2012).  Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011).. Clin Infect Dis. 55(10), 1338-51.
Spellberg, B., Ibrahim A., Roilides E., Lewis R. E., Lortholary O., Petrikkos G., et al. (2012).  Combination therapy for mucormycosis: why, what, and how?. Clin Infect Dis. 54 Suppl 1, S73-8.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.